|
Enlarge font
Reduce font
Analysts are cautiously optimistic on Teva
Citi notes that the pharmaceutical firm's growth outlook "comes with high costs".
Globes' correspondent13 Feb 08 11:59
For the whole article please click here.
|
 |
||||||||||||||||||||||||||||||||||||||||||||||||||||||
feeds
HomeMarket prices | Site map | Newsletters | Israel links | About us | Support | Report Faults | Advertise | Archive | 
Home | News | Analysis | Features | Technology guide | Real estate | Israel in depth | International
Application delivery by 